drugset / Trial / NCT00160394

Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

NCT00160394

Phase 4 Completed 130 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity.

Timeline

Start
2004-12
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.1 %
Subject Benzoyl Peroxide Other / unclassified 5 %
Subject Clindamycin Unknown 1 %

Indications